Position in PRGO
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,933,200
New position
Shares Held
180,000
first reported quarter
Ownership
0.130%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RBF Capital, LLC holds $2,535,600 across 2 Drug Manufacturers - Specialty & Generic names. PRGO ranks #1 (76.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
This page
|
180,000 | $1,933,200 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,000 | $602,400 |
All Filings in PRGO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,933,200 | 180,000 | Shares | Sole | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||